- Preview Available
- Scholarly Journal
Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia
Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemiaScientific Reports (Nature Publisher Group); London Vol. 15, Iss. 1, (2025): 10607.
DOI:10.1038/s41598-025-94373-8
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.




